Nanochannel electroporation: Researchers do precise gene therapy without a needle

Oct 16, 2011 by Pam Frost Gorder

For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.

The technique uses electricity to "shoot" bits of therapeutic biomolecules through a tiny channel and into a cell in a fraction of a second.

L. James Lee and his colleagues at Ohio State University describe the technique in the online edition of the journal Nature Nanotechnology, where they report successfully inserting specific doses of an anti-cancer gene into individual to kill them.

They have dubbed the method "nanochannel ," or NEP.

"NEP allows us to investigate how drugs and other affect and at a level not achievable by any existing techniques," said Lee, who is the Helen C. Kurtz Professor of Chemical and Biomolecular Engineering and director of the NSF Nanoscale Science and Engineering Center for Affordable of Polymeric at Ohio State.

There have long been ways to insert random amounts of into bulk quantities of for gene therapy. And fine needles can inject specific amounts of material into large cells. But most are too small for even the smallest needles to be of any use.

NEP gets around the problem by suspending a cell inside an electronic device with a reservoir of nearby. Electrical pulses push the agent out of the reservoir and through a nanometer- (billionth of a meter) scale channel in the device, through the cell wall, and into the cell. Researchers control the dose by adjusting the number of pulses and the width of the channel.

In Nature Nanotechnology, they explain how they constructed prototype devices using polymer stamps. They used individual strands of DNA as templates for the nanometer-sized channels.

Lee invented the technique for uncoiling strands of DNA and forming them into precise patterns so that they could work as wires in biologically based electronics and medical devices. But for this study, gold-coated DNA strands were stretched between two reservoirs and then etched away, in order to leave behind a nano-channel of precise dimensions connecting the reservoirs within the polymeric device.

Electrodes in the channels turn the device into a tiny circuit, and electrical pulses of a few hundred volts travel from the reservoir with the therapeutic agent through the nano-channel and into a second reservoir with the cell. This creates a strong electric field at the outlet of the nano-channel, which interacts with the cell's natural electric charge to force open a hole in the cell membrane – one large enough to deliver the agent, but small enough not to kill the cell.

In tests, they were able to insert agents into cells in as little as a few milliseconds, or thousandths of a second.

First, they tagged bits of synthetic DNA with fluorescent molecules, and used NEP to insert them into human immune cells. After a single 5-millisecond pulse, they began see spots of fluorescence scattered within the cells. They tested different pulse lengths up to 60 milliseconds – which filled the cells with fluorescence.

To test whether NEP could deliver active therapeutic agents, they inserted bits of therapeutic RNA into leukemia cells. Pulses as short as 5 milliseconds delivered enough RNA to kill some of the cells. Longer pulses – approaching 10 milliseconds – killed almost all of them. They also inserted some harmless RNA into other leukemia cells for comparison, and those cells lived.

At the moment, the process is best suited for laboratory research, Lee said, because it only works on one cell or several cells at a time. But he and his team are working on ways to inject many cells simultaneously. They are currently developing a mechanical cell-loading system that would inject up to 100,000 cells at once, which would potentially make clinical diagnostics and treatments possible.

"We hope that NEP could eventually become a tool for early cancer detection and treatment – for instance, inserting precise amounts of genes or proteins into stem cells or immune cells to guide their differentiation and changes – without the safety concerns caused by overdosing, and then placing the cells back in the body for cell-based therapy," Lee added.

He sees potential applications for diagnosing and treating leukemia, lung cancer, and other tumors. He's working with researchers at Ohio State's Comprehensive Cancer Center to explore those possibilities.

Explore further: Nanocontainers for nanocargo: Delivering genes and proteins for cellular imaging, genetic medicine and cancer therapy

Related Stories

Stem cells, potential source of cancer-fighting T cells

Sep 20, 2011

Adult stem cells from mice converted to antigen-specific T cells -- the immune cells that fight cancer tumor cells -- show promise in cancer immunotherapy and may lead to a simpler, more efficient way to use the body's immune ...

Purdue scientists treat cancer with RNA nanotechnology

Sep 14, 2005

Using strands of genetic material, Purdue University scientists have constructed tiny delivery vehicles that can carry anticancer therapeutic agents directly to infected cells, offering a potential wealth of ...

'Nanobubbles' kill cancer cells

Feb 04, 2010

(PhysOrg.com) -- Using lasers and nanoparticles, scientists at Rice University have discovered a new technique for singling out individual diseased cells and destroying them with tiny explosions. The scientists used lasers ...

Recommended for you

A nanosized hydrogen generator

Sep 20, 2014

(Phys.org) —Researchers at the US Department of Energy's (DOE) Argonne National Laboratory have created a small scale "hydrogen generator" that uses light and a two-dimensional graphene platform to boost ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

mlvols
5 / 5 (1) Oct 16, 2011
Looks like amazing research and development. Here's for the best to come out of this!